Skip to content
10-Q

Quarterly Report

ACTUATE THERAPEUTICS, INC. ACTU

0001683168-25-003705

← back to feed
Filed
May 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 14, 2025 19.62M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $3.89M
Current Liabilities Q1 2025 · Mar 31, 2025 $9.15M
Current Liabilities Q1 2025 · Dec 31, 2024 $8.8M
Total Liabilities Q1 2025 · Mar 31, 2025 $9.57M
Total Liabilities Q1 2025 · Dec 31, 2024 $9.21M
Current Assets Q1 2025 · Mar 31, 2025 $4.25M
Current Assets Q1 2025 · Dec 31, 2024 $9.21M
Total Assets Q1 2025 · Mar 31, 2025 $4.48M
Total Assets Q1 2025 · Dec 31, 2024 $9.32M
Shares Diluted Q1 2025 · Mar 31, 2024 1.54M sh
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$5.25M
Stockholders Equity Q1 2025 · Mar 31, 2024 −$107.77M
Stockholders Equity Q1 2025 · Dec 31, 2023 −$99.63M
Eps Diluted Q1 2025 · Mar 31, 2024 −$5.40
Eps Basic Q1 2025 · Mar 31, 2024 −$5.40
Sga Expense Q1 2025 · Mar 31, 2024 $912.82K
Rd Expense Q1 2025 · Mar 31, 2024 $6.86M
Net Income Q1 2025 · Mar 31, 2024 −$8.3M
Operating Income Q1 2025 · Mar 31, 2024 −$7.77M